Spotlight Therapeutics
Biotechnology, Hayward, California, 90069, United States, 11-50 Employees
Phone Number: 51********
Who is SPOTLIGHT THERAPEUTICS
Spotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo gene editing. Founded by Alex...
Read More
-
Headquarters: Hayward, California, 90069, United States
-
Date Founded: 2017
-
Employees: 11-50
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 3621
Does something look wrong? Fix it. | View contact records from SPOTLIGHT THERAPEUTICS
Spotlight Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Spotlight Therapeutics
Answer: Spotlight Therapeutics's headquarters are located at Hayward, California, 90069, United States
Answer: Spotlight Therapeutics's phone number is 51********
Answer: Spotlight Therapeutics's official website is https://spotlighttx.com
Answer: Spotlight Therapeutics's revenue is Under $1 Million
Answer: Spotlight Therapeutics's SIC: 3621
Answer: Spotlight Therapeutics has 11-50 employees
Answer: Spotlight Therapeutics is in Biotechnology
Answer: Spotlight Therapeutics contact info: Phone number: 51******** Website: https://spotlighttx.com
Answer: Spotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo gene editing. Founded by Alex Marson (UCSF), Jacob Corn (UC Berkeley), and Patrick Hsu (Salk Institute) in December of 2017, Spotlight is building its core technology platform to achieve precise in vivo gene editing in targeted cell populations. With a therapeutic focus centered on oncology, our engineered nucleases edit the genes in targeted disease organs thereby inactivating or altering the gene product. We are hiring rapidly to build out our cutting-edge research and development team. This team is responsible for preclinical development ranging from protein engineering, gene editing to immuno-oncology and in vivo safety studies. Join us and work on the next generation of gene editing therapeutics in a fast-paced and exciting environment.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month